Having been shown to overexpress CXCR4, lung cancer is a very strong predictor of poor prognosis, increased metastatic potential, and decreased survival rates, making it a good candidate target for a treatment intervention (Spiro and Porter, 2002). This evidence concerns the gene CXCR4 and lung cancer.